Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MarcS's Profile
Displaying 751-800 of 1133 result(s).
CYDY CytoDyn Inc
05/18/2021 3:36:40 AM
And, so it goes: Everyone on that t (3)
CYDY CytoDyn Inc
05/18/2021 12:21:24 AM
It's usually hard to prove corrupti (7)
CYDY CytoDyn Inc
05/17/2021 4:15:42 PM
Read the language the FDA used. The (7)
CYDY CytoDyn Inc
05/17/2021 4:04:26 PM
The doctor supporters of leronlimab (7)
CYDY CytoDyn Inc
05/17/2021 3:58:42 PM
Can the company go to the WHO, i.e. (1)
CYDY CytoDyn Inc
05/17/2021 3:50:12 PM
In the bad press is good press vein (8)
CYDY CytoDyn Inc
05/17/2021 3:39:10 PM
FDA feeling the heat. So, instead o (7)
CYDY CytoDyn Inc
05/14/2021 4:25:52 PM
It is something the shorts and bash (2)
CYDY CytoDyn Inc
05/14/2021 11:58:33 AM
Dr. Jay and Dr. Harish upstanding t (6)
CYDY CytoDyn Inc
05/14/2021 11:51:38 AM
Don't you mean "buy off" or coverin (1)
CYDY CytoDyn Inc
05/12/2021 2:18:26 PM
FDA orders quick resolution of pend (7)
CYDY CytoDyn Inc
05/10/2021 4:10:21 PM
Guy 13-months in ICU in UK. https:/ (3)
CYDY CytoDyn Inc
05/09/2021 2:54:52 PM
I think that those 28 are within th (2)
CYDY CytoDyn Inc
05/09/2021 1:45:36 PM
I'm hoping it there will be an on-d (1)
CYDY CytoDyn Inc
05/08/2021 10:11:13 PM
Mucormycosis: The 'black fungus' ma (10)
CYDY CytoDyn Inc
05/07/2021 1:42:11 AM
Okay, I just read it. I have two co (15)
CYDY CytoDyn Inc
05/07/2021 12:34:22 AM
SA hit piece. Didn't know. I have b
CYDY CytoDyn Inc
05/07/2021 12:05:24 AM
Another reason not to give an advan (10)
CYDY CytoDyn Inc
05/03/2021 10:49:59 AM
I thought the same thing you did: T (2)
CYDY CytoDyn Inc
05/02/2021 6:53:18 PM
The FDA is a classic example of a c (10)
CYDY CytoDyn Inc
05/02/2021 4:55:20 PM
Here is something even more interes (6)
CYDY CytoDyn Inc
04/29/2021 8:44:52 PM
Correct, and Meidling does not have
CYDY CytoDyn Inc
04/28/2021 7:58:03 PM
I have seen it on other posts, such (1)
CYDY CytoDyn Inc
04/28/2021 5:33:32 PM
So, out of 200,000 vials, 400 are f (6)
CYDY CytoDyn Inc
04/28/2021 5:31:12 PM
Replying to myself: Maybe you could (1)
CYDY CytoDyn Inc
04/28/2021 5:27:07 PM
It is a systemic problem in the who (6)
CYDY CytoDyn Inc
04/28/2021 4:47:37 PM
Dr. Bream open letter from yesterda (9)
CYDY CytoDyn Inc
04/25/2021 2:34:44 AM
This British story: https://www.tel (1)
CYDY CytoDyn Inc
04/23/2021 8:26:00 PM
News segment from Philippines on EU (5)
CYDY CytoDyn Inc
04/23/2021 8:22:23 PM
Doesn't he also talk about Paulson? (3)
CYDY CytoDyn Inc
04/23/2021 2:35:26 AM
Didn't Q3 2021 end on February 28, (1)
CYDY CytoDyn Inc
04/17/2021 7:58:44 PM
Where does it say that? Not allowed (6)
CYDY CytoDyn Inc
04/16/2021 7:12:12 PM
Okay, it's Friday, and you deserve (1)
CYDY CytoDyn Inc
04/16/2021 6:49:03 PM
Why (you know who you are, and so d
CYDY CytoDyn Inc
04/16/2021 5:44:33 PM
I beat you by a mere 44 seconds, so
CYDY CytoDyn Inc
04/16/2021 5:38:18 PM
FDA Revokes Emergency Use Authoriza (4)
CYDY CytoDyn Inc
04/11/2021 1:48:07 PM
The following is false information (7)
CYDY CytoDyn Inc
04/10/2021 5:31:29 PM
No, I don't believe so. It was the (6)
CYDY CytoDyn Inc
04/09/2021 6:29:01 PM
Read on Facebook stockholder group (7)
CYDY CytoDyn Inc
04/08/2021 9:16:48 PM
With a different FDA, everything yo
CYDY CytoDyn Inc
04/08/2021 8:42:14 PM
This is not a phase 3 registrationa (7)
CYDY CytoDyn Inc
04/08/2021 8:38:23 PM
Actually, what I hear all the time
CYDY CytoDyn Inc
04/08/2021 8:30:12 PM
When he was hired, I was all excite (9)
CYDY CytoDyn Inc
04/08/2021 1:06:10 AM
When I read your post below when yo (3)
CYDY CytoDyn Inc
04/07/2021 9:56:28 PM
You are mistaken as to Dr. Lalezari (5)
CYDY CytoDyn Inc
04/07/2021 7:43:02 PM
Name one thing, just one thing, tha (5)
CYDY CytoDyn Inc
04/07/2021 5:09:49 PM
Probably a short asking trying to u (1)
CYDY CytoDyn Inc
04/07/2021 5:07:41 PM
Wasn't there a question as to why h
CYDY CytoDyn Inc
04/07/2021 4:40:50 PM
Is it possible because of the delay (1)
CYDY CytoDyn Inc
03/29/2021 7:45:53 PM
You also PR it so that other patien (10)
Go to page:
  • << First
  • < Previous
  • 15
  • 16
  • Next >

Recent Articles

  • Breakthrough Research on Messenger RNA for Glioma Treatment
  • Microchip Technology Inc Shows Promising Signs of Recovery
  • Bitcoin Swift Finishes Stage 5 Presale with Strong Sales Surge
  • African Rainbow Minerals to Expand Stake in Surge Copper Corp
  • Salesforce and Other Stocks Receive Positive Analyst Upgrades
  • NICE Ltd. Sees Bearish Trend: Insights and Implications
  • Exploring UnitedHealth Group's Stock Trajectory Amid Uncertainty
  • Transforming a $100 Investment in Kinsale Capital Group
  • Fannie Mae Selects Winning Bidder for New Loan Pool Auction
  • Innovative Smart Stove Grate Enhancing Kitchen Safety
  • The Functionary Continuously Shines Among America's Fastest Firms
  • Supercapacitor Market Growth Projections to $2.84 Billion
  • Fannie Mae's Latest Community Impact Pool and Loan Overview
  • Kuehn Law Investigates Potential Breaches by Dick's Sporting Goods Management
  • Mercury Systems Records Stellar Growth and Profitability Surge
  • Exploring Agentic AI: The Future of Automated Sales Solutions
  • Recor Medical's Innovations Transform Hypertension Treatment Options
  • New Solar Supply Chain Resource Highlights U.S. Manufacturing Gaps
  • Exciting New Season: Bitget Launches LALIGA Partnership
  • TGS Equity Awards: Strengthening the Core Workforce
  • Understanding the Recent Disclosure from Apax Global Alpha Ltd
  • ProVen Growth and Income VCT plc Expands Share Issuance Strategy
  • Unite Group's Strategic Insights on Shareholder Interests Revealed
  • DIAGNOS Announces Extension of Stock Warrants for Investors
  • Morguard North American REIT Announces Distribution for August 2025
  • Analyzing Somnigroup International's Short Interest Trends
  • Analyzing Market Sentiment for GE Aerospace's Future Outlook
  • Market Insights into Intuitive Surgical's Short Selling Trends
  • Flowers Foods Adjusts Earnings Forecast Amid Market Challenges
  • Cyberscope Develops Revolutionary AI Trust Scoring Platform
  • Discovering Taiwan's Innovations: A Cultural Exchange Experience
  • Savvas Learning's myPerspectives Program Approved in Florida
  • Electrophysiology Market Growth Projections for the Future
  • Innovative CPAP Machine Revolutionizes Sleep Apnea Treatment
  • Significant Growth Anticipated in Asset Management Sector
  • Tamarack Resort Welcomes Visitors Back Amid Safety Measures
  • ProVen Growth and Income VCT plc: Recent Equity Developments
  • Replimune Group Investors Urged to Take Action Amid Lawsuit Update
  • Tiger Global Management's Bold Tech Investments Focus on Growth
  • ProVen Growth and Income VCT plc Updates Director Holdings
  • Transforming B2B Revenue with Autonomous Sales Solutions
  • NusaTrip Incorporated Launches $15 Million Public Offering
  • Allied Properties REIT Set to Distribute Units for August
  • Understanding the Growth of McKesson Investments Over 5 Years
  • Analyzing the Current Trends of the S&P 500 and Nasdaq 100
  • Investors Rally Behind UnitedHealth Amid Market Fluctuations
  • Berkshire Hathaway's Bold Moves Indicate Market Confidence
  • Investing in Goldman Sachs: A 5-Year Journey of Returns
  • Flowers Foods Faces Challenges Amid Market Strength Highlights
  • Understanding Houlihan Lokey's Performance Metrics and P/E Ratio
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site